ReviewCurrent cardiology reviews2022

Sacubitril/Valsartan: A New Dawn has Begun! A Revisited Review.

Mahmoud Abdelnabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.